← Leaderboards
Paul Robustelli
Dartmouth College
$1,979,921
Attributed
$1,979,921
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $409.6K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,979,921 · 1
By mechanism
R35$1,979,921 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- Kurt William Zilm$1,744,987
- Maria Margherita Pellegrini$1,719,000
- Ekaterina Pletneva$2,850,840
- Michael W Fanger$14,545,255
- Amy E Keating$19,695,788
Others in their field
Other Emerging Leaders on “Three Dimensional Structure”
- Peter Myler · Seattle Children'S Hospital$18,401,913
- Karla Satchell · Northwestern University At Chicago$18,350,855
- Fritzie Isip Arce-McShane · University Of Chicago$8,230,803
- Alberto La Rosa · Asociacion Civil Impacta Salud Y Educacn$7,409,538
- Siyuan Wang · Yale University$5,455,023
- Alistair N. Boettiger · Stanford University$5,389,836
Research focus
Three Dimensional StructureAndrogen ReceptorAntineoplastic AgentsProtein MisfoldingProteinsProteomeSimulationSmall MoleculeStructureTherapeutic InterventionTherapeutic TargetBindingBiologicalBiophysicsCellular AssayClinical TrialsDrug CandidateDrug DesignDrug TargetingExperimental StudyHuman DiseaseInsightLaboratoriesMeasurement
Grant awards (5)
Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor$409,560
R35 · FY2025 · GM · contact PI
Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor$409,560
R35 · FY2024 · GM · contact PI
Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor$409,560
R35 · FY2023 · GM · contact PI
Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor$409,560
R35 · FY2022 · GM · contact PI
Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor$341,681
R35 · FY2021 · GM · contact PI